Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2012
Total Assets: $50.61B
Liabilities Breakdown FY2012
Total Liabilities: $27.74B
Asset Breakdown
Total Assets: $50.61B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.88B | 5.7% |
| Accounts Receivable | $5.57B | 11.0% |
| Inventory | $5.50B | 10.9% |
| Property, Plant & Equipment | $6.32B | 12.5% |
| Goodwill | $18.86B | 37.3% |
| Intangible Assets | $7.75B | 15.3% |
| Other Assets | $3.74B | 7.4% |
Liabilities Breakdown
Total Liabilities: $27.74B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.38B | 12.2% |
| Long-Term Debt | $14.14B | 51.0% |
| Other Liabilities | $10.22B | 36.9% |